The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJETI.L Regulatory News (JETI)

  • There is currently no data for JETI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

2 Dec 2019 07:00

RNS Number : 2275V
JPMorgan European Invest Tst PLC
02 December 2019
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

JPMORGAN EUROPEAN INVESTMENT TRUST PLC

UNAUDITED HALF YEAR RESULTS FOR THE SIX MONTHS ENDED30TH SEPTEMBER 2019

Legal Entity Identifier: 549300D8SPJFHBDGXS57

Information disclosed in accordance with the DTR 4.2.2

 

Chairman's Statement

In this six month reporting period to 30th September 2019, the Company delivered positive returns to shareholders on both its Growth and Income shares. More details on the performance and dividends of each of the Company's share classes and the different ways to measure performance are provided below.

Growth Portfolio

Return to shareholders and return on net assets

The return to shareholders for the Company's Growth shares was +8.2%. This measurement of performance takes into account share price movements and income received by way of dividend. It is the industry norm and assumes that the dividend has been reinvested.

The return on net assets (debt at par value) with dividends reinvested for the Company's Growth shares was +7.9%.

The return on net assets is measured by net asset value movements and this can be looked at in different ways depending on the accounting treatment of the Company's private placement, which is a long term debt. The accounting policy of the Company, which is in line with accounting standards, recognises 'debt at par value' and amortises the debt principal. Market participants also want to know the impact of recognising 'debt at fair value', so performance is quoted for both bases. Further details on these calculations are included in the Glossary of Terms and Alternative Performance Measures on page 39 of the Company's Half Year Report.

The return on net asset value (debt at fair value) with dividends reinvested for the Company's Growth shares was +6.8%. The annual figure for this latter return is detailed in the Company's Annual Report.

For this period under review, both returns to shareholders and on net assets are below the Company's benchmark index, the MSCI Europe ex UK Index total return in sterling terms (the 'Index'), which increased by 10.2%. Looking longer term, the return on net assets over five and ten year comfortably outperformed the index.

The discount at which the Growth shares were trading below the prevailing net asset value did not change significantly since the financial year end but remained high, reflecting continuing negative market sentiment towards Europe.

Dividends

For the Company's Growth shares, the Board's aim is that annual dividend payments are sufficient to maintain the Company's investment trust status. Revenue return per share on the Growth portfolio for the six months to 30th September 2019 (calculated by reference to the average number of shares in issue over the period) amounted to 6.97 pence per share (2018: 8.01 pence per share). A first interim dividend of 4.85 pence per share (2018: 4.85 pence per share) was paid on 11th October 2019. The timing of the dividend declarations for the Growth second interim is expected to continue to be made ahead of the annual conversion opportunity in March each year.

Income Portfolio

Return to shareholders and return on net assets

The return to shareholders with dividends reinvested for the Company's Income shares was +5.4%.

The return on net assets (debt at par value) with dividends reinvested for the Company's Income shares was +7.2%.

As with the growth portfolio, for this period under review, both returns to shareholders and on net assets were below the Company's benchmark index. Looking longer term, the return on net assets over three, five and ten years comfortably outperformed the benchmark.

The return on net asset value (debt at fair value) with dividends reinvested for the Company's Income shares was +6.3%. The annual figures for this latter return is detailed in the Company's Annual Report.

As with the growth portfolio, the discount did not change significantly since the financial year end for the same reason.

Dividends

For the Company's Income shares, the Board's aim is to provide a regular stream of dividend income on a quarterly basis, subject to the availability of distributable reserves. Revenue return per share on the Income portfolio for the half year (again, calculated by reference to the average number of shares in issue over the period) amounted to 4.95 pence per share (2018: 5.01 pence per share). The first quarterly interim dividend of 1.40 pence per share (2018: 1.25 pence per share) was paid on 19th July 2019 and a second quarterly interim dividend also of 1.40 pence per share (2018: 1.25 pence per share) was paid on 11th October 2019. A third quarterly interim dividend of 1.40 pence per share (2018: 1.25 pence per share) was declared on 19th November 2019 for payment on 10th January 2020.

The timing of the dividend declarations for the Income fourth interim is expected to continue to be made ahead of the annual conversion opportunity in March each year.

In their Report below, the Investment Managers comment on some of the factors underlying the performance of the two portfolios over the Company's six month period, as well as commenting on the economic and market background.

Gearing

There has been no change in the Investment Manager's permitted gearing range, as previously set by the Board, of between 10% net cash to 20% geared. At 30th September 2019 the Growth portfolio was 8.9% geared and the Income portfolio was 5.3% geared. These levels of gearing as quoted in this Half Year Report and Financial Statements are before the application of derivatives, such as futures, which can be used by the Investment Managers to either increase or decrease the effective rate of the Company's gearing, according to market conditions. The Company's net gearing including derivatives is included with the Company's daily published net asset value.

Conversions

Shareholders in either of the two Company's share classes are able to convert some or all of their shares into shares of the other class without such disposal being treated as a disposal for capital gains purposes. The Company's next share conversion will be in March 2020 and details of the process will be posted on the Company's website in late January 2020.

Share Repurchases

The Board remains of the view that it is important to seek to address imbalances in the supply of and demand for the Company's shares and to thereby minimise the volatility and absolute level of the discount to net asset value at which the Company's shares currently trade. The Board does not wish to see the discounts widen beyond 10% (using the cum-income NAV) on an ongoing basis. The precise level and timing of repurchases pursuant to this policy depend upon prevailing market conditions. Over the six months under review the discount levels have averaged 12.0% for the Growth shares and 11.2% for the Income Shares (both at fair value and on a cum-income NAV basis). Accordingly, over the six month period the Company repurchased a total of 2,364,227 Growth shares and 338,568 Income shares.

Transfer of Reserves between the Growth and Income Portfolios

As in the previous year, the Board has exercised its power to approve transfers of retained revenue reserves from JETG to JETI in exchange for the equivalent amount of capital reserves from JETI to JETG. £1.348 million was transferred to JETI in exchange for the equivalent amount of capital reserves from JETI to JETG, being the amount of JETG's retained revenue reserve as at 31st March 2019, after payment on 5th April 2019 of the JETG 4.00p dividend. This transfer is reflected in this Half Year Report and Financial Statements.

Board of Directors

As referred to in my Chairman's Statement of the Company's Annual Report and Financial Statements to 31st March 2019, the Board was pleased to announce that Rita Dhut was appointed to the Board on 4th June 2019. Rita Dhut has 18 years' asset management experience in UK and continental European equities with roles including Director of European Equities at M&G and Head of Pan European Equity Value Investing at Aviva Investors.

Outlook

The Board and Managers are mindful of the economic and political uncertainties of investing in Europe which currently include concerns about future economic growth the influence of populist parties and Brexit, together with ongoing trade tensions between the US and China, which impacts global stock markets. However, we think that, within the Company's risk parameters and investment methodology, positive returns are achievable over the medium and longer term.

 

For and on behalf of the Board

Josephine Dixon

Chairman

29th November 2019

 

INVESTMENT MANAGERS' REPORT

Review

The Company's half year to 30th September 2019, saw markets in Europe ex UK trade modestly higher in sterling terms. In many ways the investment background deteriorated: growth expectations were downgraded everywhere as trade suffered from the continuing trade tensions between the US and China. The slowdown was particularly acute in manufacturing, with confidence indicators reaching recessionary levels. The manufacturing sector is, though, less significant in developed markets, and services remained fairly buoyant, boosted by continued rises in overall employment and contained inflation helping increases in real incomes.

Central Banks have become unequivocally dovish, with the US Federal Reserve, having signalled higher rates at the end of 2018, changing tack and embarking on a new easing cycle. The European Central Bank unveiled a new programme of asset purchases, and also committed to ultra-low interest rates. Inflation has failed to lift off anywhere in this cycle, and there are few signs of inflationary pressure building.

The slowdown in economic growth had a negative impact on profits expectations, and whereas at the start of the year European equities were expected to see increases of around 8%, as of the time of writing this has been revised to less than 1% for 2019. Europe is not alone in seeing pressure on earnings, which are flat in the US, and falling in the UK, Japan, and Emerging Markets.

Against this background both of the Company's share classes saw NAV performance lag the market. In the Income class dividend stocks came under pressure despite the generally low interest rate environment. In the Growth class we always have an overweight position in value stocks. Unfortunately value stocks underperformed again as yield curves remained flat. This is because a flat yield curve is seen by bond markets as an indication that economic growth rates will be depressed, which is generally, not an environment that favours value stocks. The performance of value stocks has fallen since 2017, when they were achieving respectable levels of performance, but are now down to low levels not seen since the technology, media and telecoms bubble (dot.com bubble) at the turn of the millennium. We remain convinced that it is appropriate to have an exposure to value, since to our mind the market is excessively pessimistic about future economic expansion; however, in the short term it is not helping us.

Outlook

Economic growth everywhere is expected to be low in 2020, with little or no recovery from 2019 levels. The dampening impact on confidence is coming from the political arena, whether that is trade tensions as the US flexes its global muscles, or more locally with continued uncertainty over Brexit. In contrast, monetary policy is supportive, and investors are facing a challenge as they try to generate returns in a world of zero or negative interest rates. In this environment equities which yield substantially more than cash have their attractions, and we think that they should be a core source of growth for investors.

 

Stephen Macklow-Smith

Alexander Fitzalan Howard

Michael Barakos

Thomas Buckingham

Investment Managers

29th November 2019

 

 

 

Interim Management Report

The Company is required to make the following disclosures in its half year report:

Principal Risks and Uncertainties

The Principal Risks and uncertainties faced by the Company fall into the following broad categories: investment and strategy; accounting, legal and regulatory; corporate governance and shareholder relations; operational; and financial. Information on each of these areas is given in the Business Review within the Annual Report and Accounts for the year ended 31st March 2019.

Related Parties Transactions

During the first six months of the current financial year, no transactions with related parties have taken place which have materially affected the financial position or the performance of the Company.

Going Concern

The Directors believe, having considered the Company's investment objectives, risk management policies, capital management policies and procedures, nature of the portfolio and expenditure projections, that the Company has adequate resources, an appropriate financial structure and suitable management arrangements in place to continue in operational existence for the foreseeable future and, more specifically, that there are no material uncertainties relating to the Company that would prevent its ability to continue in such operation existence for at least twelve months from the date of the approval of this half yearly financial report. For these reasons, they consider there is reasonable evidence to continue to adopt the going concern basis in preparing the accounts.

Directors' Responsibilities

The Board of Directors confirms that, to the best of its knowledge:

(i) the condensed set of financial statements contained within the half yearly financial report has been prepared in accordance with FRS 104 'Interim Financial Reporting' and gives a true and fair view of the state of affairs of the Company and of the assets, liabilities, financial position and net return of the Company, as at 30th September 2019, as required by the UK Listing Authority Disclosure and Transparency Rules 4.2.4R; and

(ii) the interim management report includes a fair review of the information required by 4.2.7R and 4.2.8R of the UK Listing Authority Disclosure and Transparency Rules.

In order to provide these confirmations, and in preparing these financial statements, the Directors are required to:

• select suitable accounting policies and then apply them consistently;

• make judgements and accounting estimates that are reasonable and prudent;

• state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and

• prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business;

and the Directors confirm that they have done so.

 

For and on behalf of the Board

Josephine DixonChairman

29th November 2019

 

 

 

statement of comprehensive income

For the six months ended 30th September 2019

 

 

 

 



(Unaudited) (Unaudited) (Unaudited)

Six months ended Six months ended Six months ended

30th September 2019 30th September 2018 31st March 2019

Revenue Capital Total Revenue Capital Total Revenue Capital Total

£'000 £'000 £'000 £'000 £'000 £'000 £'000 £'000 £'000

Gains/(losses) on investments

and derivatives held at fair

value through profit or loss - 20,908 20,908 - 11,690 11,690 - (16,502) (16,502)

Net foreign currency

(losses)/gains - (113) (113) - (246) (246) - 1,266 1,266

Income from investments 12,352 - 12,352 13,314 - 13,314 17,864 - 17,864

Interest receivable and similar

income 170 - 170 37 - 37 120 - 120

Gross return/(loss) 12,522 20,795 33,317 13,351 11,444 24,795 17,984 (15,236) 2,748

Management fee (591) (1,129) (1,720) (613) (1,171) (1,784) (1,186) (2,265) (3,451)

Other administrative expenses (443) - (443) (461) - (461) (840) - (840)

Net return/(loss) before

finance costs and taxation 11,488 19,666 31,154 12,277 10,273 22,550 15,958 (17,501) (1,543)

Finance costs (220) (425) (645) (233) (447) (680) (441) (850) (1,291)

Net return/(loss) before

taxation 11,268 19,241 30,509 12,044 9,826 21,870 15,517 (18,351) (2,834)

Taxation (1,302) - (1,302) (1,120) - (1,120) (872) - (872)

Net return/(loss) after

taxation 9,966 19,241 29,207 10,924 9,826 20,750 14,645 (18,351) (3,706)

Return/(loss) per share (note 3):

Growth share 6.97p 16.76p 23.73p 8.01p 7.81p 15.82p 10.68p (18.71)p (8.03)p

Income share 4.95p 7.21p 12.16p 5.01p 4.07p 9.08p 6.79p (4.71)p 2.08p

 

 

 

statement of changes in equity

For the six months ended 30th September 2019



 

Called up

 

Capital

 

 

 

 

share

Share

redemption

Capital

Revenue

 

 

capital

premium

reserve

reserves1

reserve1

Total

 

£'000

£'000

£'000

£'000

£'000

£'000

Six months ended 30th September 2019

 

 

 

 

 

 

(Unaudited)

 

 

 

 

 

 

At 31st March 2019

 4,975

 103,826

 15,149

 271,714

 12,166

407,830

Repurchase and cancellation of the

 

 

 

 

 

 

Company's own shares

 (126)

-

 126

 (7,413)

-

 (7,413)

Net return

-

-

-

 19,241

 9,966

 29,207

Dividends paid in the period (note 4)

-

-

-

-

 (6,813)

 (6,813)

At 30th September 2019

 4,849

 103,826

 15,275

 283,542

 15,319

422,811

Six months ended 30th September 2018

 

 

 

 

 

 

(Unaudited)

 

 

 

 

 

 

At 31st March 2018

 5,023

 100,773

 15,062

 296,538

 8,741

426,137

Repurchase and cancellation of the

 

 

 

 

 

 

Company's own shares

 (27)

 -

 27

 (1,657)

-

(1,657)

Net return

 -

 -

-

9,826

10,924

 20,750

Dividends paid in the period (note 4)

 -

 -

-

-

 (5,159)

(5,159)

At 30th September 2018

 4,996

 100,773

15,089

304,707

14,506

440,071

Year ended 31st March 2019 (Audited)

 

 

 

 

 

 

At 31st March 2018

 5,023

 100,773

 15,062

 296,538

 8,741

426,137

Repurchase and cancellation of the

 

 

 

 

 

 

Company's own shares

(48)

 -

48

(3,381)

-

 (3,381)

Share conversions during the year

-

3,053

39

 (3,092)

 -

 -

Net (loss)/return

-

 -

-

 (18,351)

14,645

(3,706)

Dividends paid in the year (note 4)

-

 -

 -

 -

(11,220)

(11,220)

At 31st March 2019

4,975

103,826

15,149

271,714

12,166

407,830

 

1 These reserves form the distributable reserves of the Company and may be used to fund distributions to investors via dividend payments.

 

 

 

 

statement of financial position

At 30th September 2019

 

(Unaudited)

30th September 2019

(Unaudited)

(Audited)

 

30th September

31st March

 

 

 

 

2019

2018

 

Growth

Income

Total

Total

Total

 

£'000

£'000

£'000

£'000

£'000

Fixed assets

 

 

 

 

 

Investments held at fair value through

 

 

 

 

 

profit or loss

 263,026

 191,018

 454,044

 471,308

430,366

Current assets

 

 

 

 

 

Derivative financial assets

 50

 78

 128

289

 397

Debtors

 3,481

 4,829

 8,310

 2,196

 4,558

Cash and cash equivalents

 8,874

 16,868

 25,742

 25,193

 29,187

 

 12,405

 21,775

 34,180

 27,678

 34,142

Current liabilities

 

 

 

 

 

Creditors: amounts falling due within

 

 

 

 

 

one year

 (7,957)

 (12,993)

 (20,950)

(13,590)

(13,169)

Derivative financial liabilities

 (338)

 (91)

 (429)

(1,005)

(625)

Net current assets

 4,110

 8,691

 12,801

 13,083

 20,348

Total assets less current liabilities

 267,136

 199,709

 466,845

 484,391

 450,714

Creditors: amounts falling due after

 

 

 

 

 

more than one year

 (25,660)

 (18,374)

 (44,034)

(44,320)

(42,884)

Net assets

 241,476

 181,335

 422,811

 440,071

 407,830

Capital and reserves

 

 

 

 

 

Called up share capital

 2,754

 2,095

 4,849

 4,996

 4,975

Share premium reserve

 14,709

 89,117

 103,826

 100,773

 103,826

Capital redemption reserve

 13,852

 1,423

 15,275

 15,089

 15,149

Capital reserves

 203,819

 79,723

 283,542

 304,707

 271,714

Revenue reserve

 6,342

 8,977

 15,319

 14,506

 12,166

Total shareholders' funds

 241,476

 181,335

 422,811

 440,071

 407,830

Net asset values (note 5):

 

 

 

 

 

Net asset value per Growth share

 

 

345.3p

352.4p

324.0p

Net asset value per Income share

 

 

180.3p

181.4p

172.0p

       

 

 

 

 

 

 

 

 

 

 

 

 

 

statement of cash flows

For the six months ended 30th September 2019

 

 

(Unaudited)

(Unaudited)

(Audited)

 

Six months ended

Six months ended

Year ended

 

30th September

30th September

31st March

 

2019

2018

2019

 

£'000

£'000

£'000

Net cash outflow from operations before dividends

 

 

 

and interest

 (1,384)

 (1,571)

 (4,526)

Dividends received

 12,198

 11,635

 14,277

Interest received

 93

-

 4

Overseas tax recovered

 239

 272

 1,388

Net cash inflow from operating activities

 11,146

 10,336

 11,143

Purchases of investments and derivatives

 (132,873)

 (139,145)

 (248,805)

Sales of investments and derivatives

 133,182

 130,771

 251,740

Settlement of future contracts

 (773)

 17

 424

Settlement of foreign currency contracts

 733

 584

 438

Net cash inflow/(outflow) from investing activities

 269

 (7,773)

 3,797

Dividends paid

 (6,813)

 (5,159)

 (11,220)

Repurchase and cancellation of the Company's own shares

 (7,408)

 (1,657)

 (3,381)

Interest paid

 (637)

 (674)

 (1,291)

Repayment of bank loans

-

 (13,477)

 (13,477)

Drawdown of bank loans

-

 13,528

 13,528

Net cash outflow from financing activities

 (14,858)

 (7,439)

 (15,841)

Decrease in cash and cash equivalents

 (3,443)

 (4,876)

 (901)

Cash and cash equivalents at start of period/year

 29,187

 30,078

 30,078

Exchange movements

 (2)

 (9)

 10

Cash and cash equivalents at end of period/year

 25,742

 25,193

 29,187

Decrease in cash and cash equivalents

 (3,443)

 (4,876)

 (901)

Cash and cash equivalents consist of:

 

 

 

Cash and short term deposits

 6,246

 5,032

 6,547

Cash held in JPMorgan Euro Liquidity Fund

 19,496

 20,161

 22,640

Total

 25,742

 25,193

 29,187

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Notes to the financial statements

For the six months ended 30th September 2019

1. Financial statements

The information contained within the financial statements in this half year report has not been audited or reviewed by the Company's auditors.

The figures and financial information for the year ended 31st March 2019 are extracted from the latest published financial statements of the Company and do not constitute statutory accounts for that year. Those financial statements have been delivered to the Registrar of Companies and including the report of the auditors which was unqualified and did not contain a statement under either section 498(2) or 498(3) of the Companies Act 2006.

2. Accounting policies

The financial statements have been prepared in accordance with the Companies Act 2006, FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' of the United Kingdom Generally Accepted Accounting Practice ('UK GAAP') and with the Statement of Recommended Practice 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' (the revised 'SORP') issued by the Association of Investment Companies in November 2014 and updated in October 2019.

FRS 104, 'Interim Financial Reporting', issued by the Financial Reporting Council ('FRC') in March 2015 has been applied in preparing this condensed set of financial statements for the six months ended 30th September 2019.

All of the Company's operations are of a continuing nature.

The accounting policies applied to this condensed set of financial statements are consistent with those applied in the financial statements for the year ended 31st March 2019.

 

 3. Return/(loss) per share

 

(Unaudited)

(Unaudited)

(Audited)

 

Six months ended

Six months ended

Year ended

 

30th September

30th September

31st March

Growth Share

 2019

2018

2019

Return per share is based on the following:

 

 

 

Revenue return

4,976

 5,828

7,747

Capital return/(loss)

11,970

 5,681

(13,565)

Total return/(loss)

16,946

 11,509

(5,818)

Weighted average number of shares in issue

71,417,172

72,767,969

72,515,547

Revenue return per share

6.97p

8.01p

10.68p

Capital return/(loss) per share

16.76p

7.81p

(18.71)p

Total return/(loss) per share

23.73p

15.82p

(8.03)p

 

 

 

 

 

(Unaudited)

(Unaudited)

(Audited)

 

Six months ended

Six months ended

Year ended

 

30th September

30th September

31st March

Income share

 2019

2018

2019

Return per share is based on the following:

 

 

 

Revenue return

4,990

 5,096

6,898

Capital return/(loss)

7,271

 4,145

(4,786)

Total return

12,261

 9,241

2,112

Weighted average number of shares in issue

100,833,912

101,745,485

101,651,495

Revenue return per share

4.95p

5.01p

6.79p

Capital return/(loss) per share

7.21p

4.07p

(4.71)p

Total return per share

12.16p

9.08p

2.08p

 

 

4. Dividend

 

(Unaudited)

(Unaudited)

(Audited)

 

Six months ended

Six months ended

Year ended

 

30th September

30th September

31st March

 

 2019

2018

2019

 

£'000

£'000

£'000

Growth Share

 

 

 

Dividends paid

 

 

 

Unclaimed dividends refunded to the Company

(17)

(1)

(1)

2019 second interim dividend of 4.00p paid to

 

 

 

shareholders in April (2018: 2.00p)

2,879

1,544

1,544

2019 first interim dividend of 4.85p paid to

 

 

 

shareholders in October

-

-

3,520

Total growth share dividends paid in the period

2,862

1,543

5,063

Dividends declared

 

 

 

2019 second interim dividend of 4.00p payable to

 

 

 

shareholders in April

-

-

2,879

2020 first interim dividend of 4.85p payable to

 

 

 

shareholders in October (2019: 4.85p)

3,411

3,520

-

Total growth share dividends declared

3,411

3,520

2,879

 

 

 

 

Income Share

 

 

 

Dividends paid

 

 

 

2019 fourth interim dividend of 2.50p paid to

 

 

 

shareholders in April (2018: 2.50p)

2,538

2,344

2,344

2020 first interim dividend of 1.40p paid to

 

 

 

shareholders in July (2019: 1.25p)

1,413

1,272

1,272

2019 second interim dividend of 1.25p paid to

 

 

 

shareholders in October

-

-

1,271

2019 third interim dividend of 1.25p paid to

 

 

 

shareholders in January

-

-

1,270

Total income share dividends paid in the period

3,951

3,616

6,157

Dividends declared

 

 

 

2019 fourth interim dividend of 2.50p payable to

 

 

 

shareholders in April

-

-

2,538

2020 second interim dividend of 1.40p payable to

 

 

 

shareholders in October (2019: 1.25p)

1,409

1,272

-

Total income share dividends declared

1,409

1,272

2,538

      

The combined total of growth and income dividends paid and declared is identified in Statement of Changes in Equity above.

 

5. Net asset value per share

 

(Unaudited)

(Unaudited)

(Audited)

 

Six months ended

Six months ended

Year ended

 

30th September

30th September

31st March

 

 2019

2018

2019

Growth Share

 

 

 

Net assets (£'000)

241,476

255,676

234,291

Number of shares in issue

69,941,803

72,554,097

72,306,030

Net asset value per share

345.3p

352.4p

324.0p

Income Share

 

 

 

Net assets (£'000)

181,335

184,395

173,539

Number of shares in issue

100,575,498

101,645,224

100,914,066

Net asset value per share

180.3p

181.4p

172.0p

 

 

Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

29th November 2019

For further information, please contact:

Paul Winship

For and on behalf of

JPMorgan Funds Limited, Secretary

020 7742 4000

 

JPMORGAN FUNDS LIMITED

ENDS

A copy of the half year will be submitted to the National Storage Mechanism and will shortly be available for inspection at www.hemscott.com/nsm.do

The half year will also shortly be available on the Company's website at www.jpmeuropean.co.uk where up to date information on the Company, including daily NAV and share prices, factsheets and portfolio information can also be found.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR BRBDBRDDBGCC
Date   Source Headline
3rd Feb 20226:00 pmRNSJPMorgan European Investment Trust
3rd Feb 20222:57 pmRNSResults of Restructuring and Amendments to Listing
1st Feb 202211:25 amRNSNet Asset Value(s)
1st Feb 20229:19 amRNSTotal Voting Rights
31st Jan 202212:13 pmRNSGearing Announcement
31st Jan 202211:54 amRNSNet Asset Value(s)
28th Jan 202211:49 amRNSNet Asset Value(s)
27th Jan 202211:20 amRNSNet Asset Value(s)
26th Jan 202212:01 pmRNSNet Asset Value(s)
25th Jan 202211:58 amRNSNet Asset Value(s)
24th Jan 20221:52 pmRNSGearing Announcement
24th Jan 20221:01 pmRNSNet Asset Value(s)
24th Jan 202212:35 pmRNSResults of Meetings and Transaction Update
21st Jan 202212:28 pmRNSNet Asset Value(s)
20th Jan 202212:12 pmRNSNet Asset Value(s)
19th Jan 202211:45 amRNSNet Asset Value(s)
18th Jan 202211:06 amRNSNet Asset Value(s)
17th Jan 20224:59 pmRNSTransaction in Own Shares
17th Jan 202212:42 pmRNSTen Largest Investments
17th Jan 202211:51 amRNSGearing Announcement
17th Jan 202211:45 amRNSNet Asset Value(s)
14th Jan 202211:17 amRNSNet Asset Value(s)
13th Jan 202210:52 amRNSNet Asset Value(s)
12th Jan 20225:27 pmRNSTransaction in Own Shares
12th Jan 202210:39 amRNSNet Asset Value(s)
11th Jan 202210:58 amRNSNet Asset Value(s)
10th Jan 202211:46 amRNSGearing Announcement
10th Jan 202211:07 amRNSNet Asset Value(s)
7th Jan 202211:02 amRNSNet Asset Value(s)
6th Jan 202211:12 amRNSNet Asset Value(s)
5th Jan 202211:14 amRNSNet Asset Value(s)
4th Jan 20222:56 pmRNSTotal Voting Rights
4th Jan 20221:21 pmRNSGearing Announcement
4th Jan 20221:18 pmRNSNet Asset Value(s)
31st Dec 202111:46 amRNSNet Asset Value(s)
30th Dec 202111:04 amRNSNet Asset Value(s)
29th Dec 20215:21 pmRNSTransaction in Own Shares
29th Dec 202112:14 pmRNSGearing Announcement
29th Dec 202111:16 amRNSNet Asset Value(s)
24th Dec 202111:31 amRNSNet Asset Value(s)
23rd Dec 202110:44 amRNSNet Asset Value(s)
22nd Dec 202110:43 amRNSNet Asset Value(s)
22nd Dec 202110:13 amRNSDirectorate Change
21st Dec 202111:20 amRNSNet Asset Value(s)
20th Dec 20214:34 pmRNSPublication of Circular
20th Dec 202111:18 amRNSNet Asset Value(s)
20th Dec 202110:54 amRNSGearing Announcement
17th Dec 202111:27 amRNSNet Asset Value(s)
16th Dec 202111:09 amRNSNet Asset Value(s)
15th Dec 20214:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.